arrow
G

Grennady Wirjanata

南洋理工大学
H指数:19
被引数:2,321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity
MBIO
IF4.7
2024-06-120
OAAI
Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia

在印度尼西亚巴布亚引入基于青蒿素的联合疗法之前和之后,氯喹和哌喹对恶性疟原虫和间日疟原虫的纵向离体和分子趋势

2021-12-013
OAAI
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance
2021-07-2130
OA
Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
2020-05-078
OAAI
3,3′-Disubstituted 5,5′-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity
2019-02-0414
OAAI
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria (vol 62, e00012-18, 2018
2018-11-010
OAAI
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria
2018-09-0158
OAAI
Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes

恶性疟原虫和间日疟原虫表现出相反的氯喹抗性逆转表型

2017-08-0110
OAAI
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
2017-05-2457
OAAI
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
2016-10-0478
OAAI
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling
2016-10-0436
OAAI